The FDA's Alzheimer's mistake is already worsening

Frederick News Post

Jun 28, 2021

When the U.S. Food and Drug Administration approved Biogen Inc.'s controversial Alzheimer's drug Aduhelm earlier this month without firm evidence that the drug helps patients, it c…